iBio, Inc. (IBIO)
1.37
-0.03
(-2.14%)
USD |
NASDAQ |
Aug 28, 16:00
1.37
0.00 (0.00%)
After-Hours: 18:39
iBio 30-Day Average Daily Volume : 686427.5 for Aug. 27, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 27, 2026 | 686427.5 |
| August 26, 2026 | 722856.7 |
| August 25, 2026 | 747023.8 |
| August 24, 2026 | 769457.5 |
| August 21, 2026 | 788178.6 |
| August 20, 2026 | 792830.7 |
| August 19, 2026 | 765616.7 |
| August 18, 2026 | 787604.4 |
| August 17, 2026 | 709885.4 |
| August 14, 2026 | 705808.1 |
| August 13, 2026 | 713855.9 |
| August 12, 2026 | 865162.9 |
| August 11, 2026 | 859860.2 |
| August 10, 2026 | 884695.1 |
| August 07, 2026 | 919150.4 |
| August 06, 2026 | 916989.1 |
| August 05, 2026 | 916256.7 |
| August 04, 2026 | 937143.3 |
| August 03, 2026 | 951091.0 |
| July 31, 2026 | 965817.4 |
| July 30, 2026 | 997236.5 |
| July 29, 2026 | 1.018M |
| July 28, 2026 | 1.017M |
| July 27, 2026 | 997911.4 |
| July 24, 2026 | 974841.1 |
| Date | Value |
|---|---|
| July 23, 2026 | 951304.2 |
| July 22, 2026 | 949483.5 |
| July 21, 2026 | 958524.2 |
| July 20, 2026 | 1.022M |
| July 17, 2026 | 1.037M |
| July 16, 2026 | 1.041M |
| July 15, 2026 | 1.030M |
| July 14, 2026 | 1.015M |
| July 13, 2026 | 988714.9 |
| July 10, 2026 | 977688.9 |
| July 09, 2026 | 967633.9 |
| July 08, 2026 | 965800.0 |
| July 07, 2026 | 935860.1 |
| July 06, 2026 | 967930.4 |
| July 02, 2026 | 976840.4 |
| July 01, 2026 | 977373.7 |
| June 30, 2026 | 834528.7 |
| June 29, 2026 | 834030.7 |
| June 26, 2026 | 820247.5 |
| June 25, 2026 | 792552.7 |
| June 24, 2026 | 793397.2 |
| June 23, 2026 | 802109.4 |
| June 22, 2026 | 832242.5 |
| June 18, 2026 | 814486.9 |
| June 17, 2026 | 848200.1 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Capricor Therapeutics, Inc. | 10.70M |
| Ocugen, Inc. | 4.167M |
| CytomX Therapeutics, Inc. | 2.678M |
| ACADIA Pharmaceuticals, Inc. | 1.626M |
| Alnylam Pharmaceuticals, Inc. | 2.034M |